Esperion Therapeutics Inc. has successfully secured financing, which will be specifically used to support its acquisition of Corstasis Therapeutics.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Corstasis Therapeutics is the developer of the innovative drug Enbumyst. This acquisition will significantly enhance Esperion's R&D pipeline and market competitiveness in the relevant therapeutic field.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
BUZZ - Amgen raises 2026 profit and revenue forecasts; shares fall
路透社•2026/11/03 22:04
BRIEF-Triple Flag Precious Metals Q3 Adjusted Net Income USD 53.1 Million
Reuters•2026/11/03 22:03
Crypto prices
More
Bitcoin
BTC
$77,727.1
+1.30%
Ethereum
ETH
$2,290.76
+1.70%
Tether USDt
USDT
$0.9989
+0.07%
BNB
BNB
$699.99
+0.21%
XRP
XRP
$1.28
+2.37%
USDC
USDC
$0.9998
+0.03%
Solana
SOL
$93.49
+1.67%
TRON
TRX
$0.3227
+1.32%
Hyperliquid
HYPE
$85.67
+1.69%
Zcash
ZEC
$1,224.37
+6.20%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now